Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery

被引:165
作者
Duceppe, Nicolas [1 ,2 ]
Tabrizian, Maryam [1 ,2 ,3 ]
机构
[1] McGill Univ, Dept Biomed Engn, Fac Med, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Ctr Biorecognit & Biosensors, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Fac Dent, Montreal, PQ H3A 2B4, Canada
关键词
chitosan; drug delivery; gene delivery; nanocarrier; nanoparticle; transfection; SELF-AGGREGATED NANOPARTICLES; NASAL ABSORPTION ENHANCEMENT; MOLECULAR-WEIGHT CHITOSAN; CANCER-THERAPY; TRANSFECTION EFFICIENCY; BIOLOGICAL-PROPERTIES; PROLONGED DELIVERY; DNA NANOPARTICLES; PEPTIDE DELIVERY; CARCINOMA-CELLS;
D O I
10.1517/17425247.2010.514604
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Importance of the field: This review aims to provide an overview of state-of-the-art chitosan-based nanosized carriers for the delivery of therapeutic agents. Chitosan nanocarriers are smart delivery systems owing to the possibility of their property alterations with various approaches, which would confer them with the possibility of spatiotemporal delivery features. Areas covered in this review: The focus of this review is principally on those aspects that have not often been addressed in other reviews. These include the influence of physicochemical properties of chitosan on delivery mechanisms and chitosan modification with a variety of ligand moieties specific for cell surface receptors to increase recognition and uptake of nanocarriers into cells through receptor-mediated endocytosis. Multiple examples that demonstrate the advantages of chitosan-based nanocarriers over other delivery systems of therapeutic agents are highlighted. Particular emphasis is given to the alteration of material properties by functionalization or combination with other polymers for their specific applications. Finally, structural and experimental parameters influencing transfection efficiency of chitosan-based nanocarriers are presented for both in vitro and in vivo gene delivery. What the reader will gain: The readers will acquire knowledge of parameters influencing the properties of the chitosan-based nanocarriers for delivery of therapeutic agents (genetic material or drugs) in vitro and in vivo. They will get a better idea of the strategies to be adapted to tune the characteristics of chitosan and chitosan derivatives for specific delivery applications. Take home message: Chitosan is prone to chemical and physical modifications, and is very responsive to environmental stimuli such as temperature and pH. These features make chitosan a smart material with great potential for developing multifunctional nanocarrier systems to deliver large varieties of therapeutic agents administrated in multiple ways with reduced side effects.
引用
收藏
页码:1191 / 1207
页数:17
相关论文
共 115 条
[41]
Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin [J].
Huang, Xuan ;
Du, Yong-Zhong ;
Yuan, Hong ;
Hu, Fu-Qiang .
CARBOHYDRATE POLYMERS, 2009, 76 (03) :368-373
[42]
Pulmonary inflammation caused by chitosan microparticles [J].
Huang, YC ;
Vieira, A ;
Huang, KL ;
Yeh, MK ;
Chiang, CH .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 75A (02) :283-287
[43]
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles [J].
Hwang, Ho-Young ;
Kim, In-San ;
Kwon, Ick Chan ;
Kim, Yong-Hee .
JOURNAL OF CONTROLLED RELEASE, 2008, 128 (01) :23-31
[44]
Mechanism of cell transfection with plasmid/chitosan complexes [J].
Ishii, T ;
Okahata, Y ;
Sato, T .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1514 (01) :51-64
[45]
Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo [J].
Issa, Mohamed M. ;
Koping-Hoggard, Magnus ;
Tommeraas, Kristoffer ;
Varum, Kjell M. ;
Christensen, Bjorn E. ;
Strand, Sabina P. ;
Artursson, Per .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (01) :103-112
[46]
Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery [J].
Jain, Dharmendra ;
Banerjee, R. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2008, 86B (01) :105-112
[47]
Chitosan nanoparticles as delivery systems for doxorubicin [J].
Janes, KA ;
Fresneau, MP ;
Marazuela, A ;
Fabra, A ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267
[48]
Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats [J].
Jo, Hyung Gon ;
Min, Kyung Hyun ;
Nam, Tae Hwan ;
Na, Seong Ju ;
Park, Jae Hyung ;
Jeong, Seo Young .
ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (07) :918-923
[49]
Characterization of pilocarpine-loaded chitosan/carbopol nanoparticles [J].
Kao, HJ ;
Lin, HR ;
Lo, YL ;
Yu, SP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (02) :179-186
[50]
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection [J].
Kiang, T ;
Wen, H ;
Lim, HW ;
Leong, KW .
BIOMATERIALS, 2004, 25 (22) :5293-5301